Using a partially observable Markov chain model to assess colonoscopy screening strategies - A cohort study
暂无分享,去创建一个
[1] P. Maisonneuve,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.
[2] Hermann Brenner,et al. Cost-effectiveness of colonoscopy in screening for colorectal cancer. , 2002, Archives of internal medicine.
[3] B. Levin,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.
[4] Lisa M. Maillart,et al. Assessing Dynamic Breast Cancer Screening Policies , 2008, Oper. Res..
[5] Brian T. Denton,et al. Optimization of Prostate Biopsy Referral Decisions , 2012, Manuf. Serv. Oper. Manag..
[6] B. Manns,et al. Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation , 2010, PLoS medicine.
[7] Timothy D. Imler,et al. The effect of colonoscopy preparation quality on adenoma detection rates. , 2012, Gastrointestinal endoscopy.
[8] Robert W. Klein,et al. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages , 2000 .
[9] Michael Pignone,et al. Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults , 2005 .
[10] D. Rex,et al. Corrigendum: American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2009 .
[11] I. Sobhani,et al. Cost-Effectiveness of Mass Screening for Colorectal Cancer: Choice of Fecal Occult Blood Test and Screening Strategy , 2011, Diseases of the colon and rectum.
[12] E. Arias,et al. United States life tables, 2006. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[13] J. Habbema,et al. Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. , 2011, Gastroenterology.
[14] Amy B. Knudsen,et al. Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.
[15] Graham A. Colditz,et al. Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.
[16] A. N. Lee,et al. U. S. NATIONAL CENTER FOR HEALTH STATISTICS , 1968 .
[17] P. Grenier,et al. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests. , 2012, European journal of radiology.
[18] A. Verbeek,et al. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: A cost‐effectiveness analysis , 2011, International journal of cancer.
[19] Joel Lexchin,et al. Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review , 2010, PLoS medicine.
[20] D. Rex,et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.
[21] Martin Krapcho,et al. SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) , 2012 .
[22] Lijun Wang,et al. Development of a simulation model of colorectal cancer , 2007, TOMC.
[23] Angela Mariotto,et al. Cancer Intervention and Surveillance Modeling Network (CISNET) , 2001, Journal of Investigative Medicine.
[24] Rob Boer,et al. The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..
[25] Carolyn M Rutter,et al. An Evidence-Based Microsimulation Model for Colorectal Cancer: Validation and Application , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[26] A. Fendrick,et al. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. , 2004, Gastroenterology.
[27] Turgay Ayer,et al. OR Forum - A POMDP Approach to Personalize Mammography Screening Decisions , 2012, Oper. Res..
[28] Michael E. Chernew,et al. Willingness to Pay for a Quality-adjusted Life Year , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.
[29] Michael Devetsikiotis,et al. An adaptive approach to accelerated evaluation of highly available services , 2007, TOMC.
[30] J D Habbema,et al. Endoscopic colorectal cancer screening: a cost-saving analysis. , 2000, Journal of the National Cancer Institute.
[31] S. Peacock,et al. Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, Canada. , 2012, European journal of cancer.
[32] Brian T. Denton,et al. Optimization of PSA Screening Policies , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[33] Daniel Frederick Cubbage. Simulation of Colorectal Cancer: The natural history of disease , 2004 .
[34] Barry L. Nelson,et al. Numerical Methods for Fitting and Simulating Autoregressive-to-Anything Processes , 1998, INFORMS J. Comput..
[35] A. Fendrick,et al. Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[36] Stephen D. Roberts,et al. Probabilistic cost-effectiveness comparison of screening strategies for colorectal cancer , 2009, TOMC.
[37] Bernadette Mazurek Melnyk,et al. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.
[38] Perry J Pickhardt,et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.
[39] M. Mcgrath. Cost Effectiveness in Health and Medicine. , 1998 .
[40] A. Jemal,et al. Global Cancer Statistics , 2011 .
[41] Eric J Feuer,et al. Dynamic Microsimulation Models for Health Outcomes , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[42] Janneke Wilschut,et al. At what costs will screening with CT colonography be competitive? A cost‐effectiveness approach , 2009, International journal of cancer.
[43] Douglas K Rex,et al. Corrigendum: American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2009, The American Journal of Gastroenterology.
[44] James J. Nutaro,et al. On constructing optimistic simulation algorithms for the discrete event system specification , 2008, TOMC.
[45] J. GarcíaSánchez. [Colonoscopic polypectomy and long-term prevention of colorectal cancer deaths]. , 2012 .
[46] R. Hayward,et al. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. , 2001, The American journal of medicine.